**Summary:**A significant recall of blood pressure medication, prazosin hydrochloride, has been announced in the U.S. due to potential cancer risks. The U.S. Food and Drug Administration (FDA) flagged the issue in early October, with the recall officially announced on November 1st. The recall affects nearly 590,000 bottles of the one milligram, two milligram, and five milligram capsules from Teva Pharmaceuticals USA and Amerisource Health Services. The FDA classified the incident as a Class Two recall, indicating a low but not zero chance of temporary health consequences. The recall is due to the presence of nitrosamine impurities, which are considered potential carcinogens. The FDA advises those affected to consult their pharmacy or healthcare provider and not to stop the medication suddenly without medical advice.

The Daily News Now! — Every city. Every story. AI-powered.

Hosted on Acast. See acast.com/privacy for more information.